Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 13812551
[patent_doc_number] => 10183033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Triptolide prodrugs
[patent_app_type] => utility
[patent_app_number] => 15/465377
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11587
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465377 | Triptolide prodrugs | Mar 20, 2017 | Issued |
Array
(
[id] => 13986283
[patent_doc_number] => 20190062299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/087175
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087175 | Processes for the preparation of heteroaryl carboxylic acids | Mar 20, 2017 | Issued |
Array
(
[id] => 15163147
[patent_doc_number] => 10487053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine
[patent_app_type] => utility
[patent_app_number] => 16/073388
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3695
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073388
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073388 | Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine | Mar 16, 2017 | Issued |
Array
(
[id] => 14518897
[patent_doc_number] => 10336695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt
[patent_app_type] => utility
[patent_app_number] => 16/073359
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7642
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073359 | Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt | Mar 16, 2017 | Issued |
Array
(
[id] => 14500969
[patent_doc_number] => 20190194139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => CYCLIC KETO-AMIDE COMPOUNDS AS CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/083189
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083189 | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof | Mar 7, 2017 | Issued |
Array
(
[id] => 12343353
[patent_doc_number] => 09949948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions
[patent_app_type] => utility
[patent_app_number] => 15/452065
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 20506
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15452065
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/452065 | Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions | Mar 6, 2017 | Issued |
Array
(
[id] => 12526875
[patent_doc_number] => 10005801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Compounds for pH-controlled release of hydrogen sulfide
[patent_app_type] => utility
[patent_app_number] => 15/447797
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 8521
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447797
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/447797 | Compounds for pH-controlled release of hydrogen sulfide | Mar 1, 2017 | Issued |
Array
(
[id] => 13063085
[patent_doc_number] => 10052312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
[patent_app_type] => utility
[patent_app_number] => 15/447205
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137721
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1074
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15447205
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/447205 | Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use | Mar 1, 2017 | Issued |
Array
(
[id] => 16572892
[patent_doc_number] => 10894805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one
[patent_app_type] => utility
[patent_app_number] => 16/082025
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6870
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082025 | Prodrugs of the selective progesterone receptor modulator (SPRM) (11.beta.,17.beta.)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl] -17-(pentafluoroethyl)estra-4,9-dien-3-one | Feb 28, 2017 | Issued |
Array
(
[id] => 15483043
[patent_doc_number] => 10556854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Bacterial efflux pump inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/078576
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15210
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078576 | Bacterial efflux pump inhibitors | Feb 22, 2017 | Issued |
Array
(
[id] => 11668810
[patent_doc_number] => 20170157530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'FURAN-2,5-DICARBOXYLIC ACID PURGE PROCESS'
[patent_app_type] => utility
[patent_app_number] => 15/435362
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6740
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435362 | Furan-2,5-dicarboxylic acid purge process | Feb 16, 2017 | Issued |
Array
(
[id] => 12219116
[patent_doc_number] => 20180057474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => '2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals'
[patent_app_type] => utility
[patent_app_number] => 15/435075
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17339
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435075 | 2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals | Feb 15, 2017 | Abandoned |
Array
(
[id] => 12118710
[patent_doc_number] => 20180002296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE'
[patent_app_type] => utility
[patent_app_number] => 15/435119
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15637
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435119
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435119 | S-TRIAZOLYL ALPHA-MERCAPTO ACETANILIDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | Feb 15, 2017 | Abandoned |
Array
(
[id] => 11669964
[patent_doc_number] => 20170158684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'NOVEL COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRAL DISEASES CONTAINING SAME AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 15/433536
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27476
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433536 | Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient | Feb 14, 2017 | Issued |
Array
(
[id] => 16184430
[patent_doc_number] => 10717734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/076985
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 38657
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 466
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076985 | Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 16184429
[patent_doc_number] => 10717733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/076979
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 42839
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 442
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076979 | Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 13867293
[patent_doc_number] => 20190029987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => DIMETHYL FUMARATE (DMF) FOR PREVENTION OR TREATMENT OF GOUT, ACNE, DIABETES, VITILIGO AND/OR PYODERMA GANGRENOSUM
[patent_app_type] => utility
[patent_app_number] => 16/077476
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077476 | DIMETHYL FUMARATE (DMF) FOR PREVENTION OR TREATMENT OF GOUT, ACNE, DIABETES, VITILIGO AND/OR PYODERMA GANGRENOSUM | Feb 9, 2017 | Abandoned |
Array
(
[id] => 11954638
[patent_doc_number] => 20170258789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'DNA-PK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/426150
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30066
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426150 | DNA-PK inhibitors | Feb 6, 2017 | Issued |
Array
(
[id] => 13928903
[patent_doc_number] => 20190047967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => BLUE LIGHT CUTTING OPTICAL MATERIAL COMPRISING A BENZOTRIAZOLE UV ABSORBER
[patent_app_type] => utility
[patent_app_number] => 16/076426
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076426 | Blue light cutting optical material comprising a benzotriazole UV absorber | Feb 6, 2017 | Issued |
Array
(
[id] => 15422423
[patent_doc_number] => 10544124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Substituted 2-(het)arylimidazolylcarboxyamides as pesticides
[patent_app_type] => utility
[patent_app_number] => 16/076786
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30910
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 399
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076786 | Substituted 2-(het)arylimidazolylcarboxyamides as pesticides | Feb 5, 2017 | Issued |